This article provides a comprehensive roadmap for researchers, scientists, and drug development professionals engaged in multi-omics biomarker discovery for metabolic disorders.
This article provides a detailed, research-oriented analysis of biomarkers distinguishing beta cell dysfunction from insulin resistance—the two core pathological pillars of diabetes mellitus.
This comprehensive review synthesizes current research on lipid metabolism biomarkers as critical nexus points linking cancer risk and diabetes.
This article provides a comprehensive analysis for researchers, scientists, and drug development professionals on the evolving role of mitochondrial dysfunction biomarkers in metabolic syndrome (MetS).
This article provides a comprehensive analysis of Growth Differentiation Factor 15 (GDF-15) as a critical mediator in metabolic homeostasis, with a focus on its therapeutic potential for diabetes and obesity.
This comprehensive review synthesizes the latest research on the pivotal roles of the adipokines leptin and adiponectin in the pathogenesis of metabolic syndrome (MetS).
This review provides a comprehensive analysis of the current and emerging biomarker landscape for metabolic dysfunction-associated fatty liver disease (MAFLD).
This review synthesizes current research on the molecular interplay between inflammatory biomarkers, insulin resistance (IR), and the executioner protein Gasdermin D (GSDMD)-mediated pyroptosis.
This comprehensive review examines the rapidly evolving field of DNA methylation biomarkers for Type 2 Diabetes (T2D).
This article provides a comprehensive overview of metabolite-metabolite interaction network analysis, a pivotal approach in systems biology for understanding complex metabolic processes.